HERV-K and HERV-W transcriptional activity in myalgic encephalomyelitis/chronic fatigue syndrome

被引:17
|
作者
Rodrigues, Lucas S. [1 ]
da Silva Nali, Luiz H. [1 ,2 ]
Leal, Cibele O. D. [1 ]
Sabino, Ester C. [1 ,3 ]
Lacerda, Eliana M. [4 ]
Kingdon, Caroline C. [4 ]
Nacul, Luis [4 ]
Romano, Camila M. [1 ,5 ]
机构
[1] Univ Sao Paulo, Inst Med Trop Sao Paulo, Lab Virol, Rua Dr Eneas Carvalho Aguiar 470, BR-05403000 Sao Paulo, SP, Brazil
[2] Univ Santo Amaro, Posgrad Ciencias Saude, Sao Paulo, Brazil
[3] Univ Sao Paulo, Fac Med, Dept Molestias Infecciosas & Parasit, Sao Paulo, Brazil
[4] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Dept Clin Res, London, England
[5] Univ Sao Paulo, Fac Med, Hosp Clin HCFMUSP LIM52, Sao Paulo, Brazil
基金
巴西圣保罗研究基金会; 美国国家卫生研究院;
关键词
Endogenous retroviruses; HERV-W; HERV-K; Myalgic encephalomyelitis; Chronic fatigue; EXPRESSION;
D O I
10.1186/s13317-019-0122-8
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background Chronic fatigue syndrome/myalgic encephalomyelitis (CFS/MS) is an incapacitating chronic disease that dramatically compromise the life quality. The CFS/ME pathogenesis is multifactorial, and it is believed that immunological, metabolic and environmental factors play a role. It is well documented an increased activity of Human endogenous retroviruses (HERVs) from different families in autoimmune and neurological diseases, making these elements good candidates for biomarkers or even triggers for such diseases. Methods Here the expression of Endogenous retroviruses K and W (HERV-K and HERV-W) was determined in blood from moderately and severely affected ME/CFS patients through real time PCR. Results HERV-K was overexpressed only in moderately affected individuals but HERV-W showed no difference. Conclusions This is the first report about HERV-K differential expression in moderate ME/CFS. Although the relationship between HERVs and ME/CFS has yet to be proven, the observation of this phenomenon deserves further attention.
引用
收藏
页数:5
相关论文
共 50 条
  • [21] Classification of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome by Types of Fatigue
    Jason, Leonard A.
    Boulton, Aaron
    Porter, Nicole S.
    Jessen, Tricia
    Njoku, Mary Gloria
    Friedberg, Fred
    BEHAVIORAL MEDICINE, 2010, 36 (01) : 24 - 31
  • [22] Redefining Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Reply
    Clayton, Ellen Wright
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2015, 314 (01): : 85 - 86
  • [23] Mortality in patients with myalgic encephalomyelitis and chronic fatigue syndrome
    McManimen, Stephanie L.
    Devendorf, Andrew R.
    Brown, Abigail A.
    Moore, Billie C.
    Moore, James H.
    Jason, Leonard A.
    FATIGUE-BIOMEDICINE HEALTH AND BEHAVIOR, 2016, 4 (04): : 195 - 207
  • [24] A new look at chronic fatigue syndrome/myalgic encephalomyelitis
    Gibson, I.
    JOURNAL OF CLINICAL PATHOLOGY, 2007, 60 (02) : 120 - 120
  • [25] Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Real Illness
    Komaroff, Anthony L.
    ANNALS OF INTERNAL MEDICINE, 2015, 162 (12) : 871 - 872
  • [26] Prednisone against myalgic encephalomyelitis/chronic fatigue syndrome?
    Hilpusch, Frank
    TIDSSKRIFT FOR DEN NORSKE LAEGEFORENING, 2016, 136 (05) : 397 - 397
  • [27] Treatment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome RESPONSE
    Smith, M. E. Beth
    Haney, Elizabeth
    Nelson, Heidi D.
    ANNALS OF INTERNAL MEDICINE, 2015, 163 (11) : 888 - 888
  • [28] 'The Lightning Process' and chronic fatigue syndrome/myalgic encephalomyelitis
    Vallings, Rosamund
    JOURNAL OF PRIMARY HEALTH CARE, 2022, 14 (03) : 283 - 284
  • [29] Investigation of suspected chronic fatigue syndrome/myalgic encephalomyelitis
    Tveramo, Aksel
    Johnsen, Ine Baug
    TIDSSKRIFT FOR DEN NORSKE LAEGEFORENING, 2016, 136 (06) : 509 - 509
  • [30] Immunostimulation in the treatment for chronic fatigue syndrome/myalgic encephalomyelitis
    Amy D. Proal
    Paul J. Albert
    Trevor G. Marshall
    Greg P. Blaney
    Inge A. Lindseth
    Immunologic Research, 2013, 56 : 398 - 412